Bluejay Diagnostics (BJDX) news
Recent news
Bluejay Diagnostics announces closing of up to $23.7 million private placement priced at-the-market under Nasdaq rules
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) announced the closing of a private placement offering that could raise up to $23.6 million, with $8.5 million in upfront gross proceeds and an additional $15.1 million in potential proceeds if all warrants are exercised. The offering includes the sale of…
AInvest Wire · Jun 6, 2026Bluejay Diagnostics announces up to $23.6 million private placement priced at-the-market under Nasdaq rules
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) has announced a private placement offering of up to $23.6 million, priced at-the-market under Nasdaq rules. The offering includes the sale of 2,250,000 shares of common stock (or pre-funded warrants in lieu thereof) and Series F warrants to purchase up to…
AInvest Wire · Jun 2, 2026Bluejay Diagnostics and Argonaut Manufacturing Services announce strategic partnership
AInvest Wire · Jun 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.